CACaption Management, LLC
Institutional investor · Portfolio as of Q3 2023
Top Holdings1,240 positions
ACTIVISION BLIZZARD INC | 1.8M | $171.7M | 2.6% | — | — | — | Decreased — |
HORIZON THERAPEUTICS PUB L | 1.1M | $132.3M | 2.0% | — | — | — | Decreased — |
SEAGEN INC | 598,500 | $127M | 2.0% | — | — | — | Increased — |
T-MOBILE US INC | 590,000 | $82.6M | 1.3% | — | — | — | Increased — |
SAREPTA THERAPEUTICS INC | 656,100 | $79.5M | 1.2% | — | — | — | Increased — |
T-MOBILE US INC | 530,000 | $74.2M | 1.1% | — | — | — | New — |
CITIGROUP INC | 1.7M | $71M | 1.1% | $37.52 | 0.00% | 1 qtr | New 68 |
PALO ALTO NETWORKS INC | 302,400 | $70.9M | 1.1% | — | — | — | Decreased — |
CITIGROUP INC | 1.7M | $69.9M | 1.1% | — | — | — | New — |
ARGENX SE | 124,500 | $61.2M | 0.9% | — | — | — | Increased — |
ISHARES TR | 775,000 | $60.8M | 0.9% | — | — | — | Unchanged — |
ALPHABET INC | 430,000 | $56.7M | 0.9% | — | — | — | Unchanged — |
| 2.2M | $55.2M | 0.9% | — | — | — | Decreased — | |
HORIZON THERAPEUTICS PUB L | 460,200 | $53.2M | 0.8% | — | — | — | Decreased — |
SAREPTA THERAPEUTICS INC | 396,500 | $48.1M | 0.7% | — | — | — | Increased — |
CENCORA INC | 264,400 | $47.6M | 0.7% | — | — | — | New — |
SPDR SER TR | 1.1M | $46.8M | 0.7% | $38.52 | 0.00% | 1 qtr | New 57 |
KENVUE INC | 2.3M | $46.7M | 0.7% | — | — | — | New — |
SPDR SER TR | 1.1M | $45.9M | 0.7% | — | — | — | New — |
RH | 173,700 | $45.9M | 0.7% | — | — | — | New — |
Caption Management, LLC manages $6.5B across 1240 positions as of Q3 2023. Top holdings: ATVI puts (2.6%), HZNP puts (2.0%), SGEN puts (2.0%). Fund DNA: Momentum Trader. HoldingsIntel Score: 1/5.0.
Active quarter - 208 new positions, 141 exits, 81 increased. Top move: C (NEW, conviction 68). Portfolio: $6.5B across 1240 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR